GlobalRPh RX List - KOSELUGO
- Product / population
- Selected selumetinib renal pharmacokinetics; full formulation/age-specific regimen remains necessary.
- Renal measure
- Cockcroft-Gault CrCl <15 mL/min with dialysis in the study.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
No clinically significant exposure difference was observed in ESRD patients requiring dialysis. This observation does not reproduce the complete age/BSA/formulation dosing tables or provide a post-dialysis supplement. The separate hepatic dose modifications must not be relabeled as renal modifications.